Stellaromics
Healthcare & Life Sciences
Recent Finacing
Series A
Recent Raise
$25M
Stellaromics is a Boston-based company that has developed in situ spatial multi-omics technology to accelerate the development of novel drug treatments.
Focus Areas
Spatial Multi-Omics Technology
Drug Development Acceleration
In Situ 3D Profiling
Innovation Investment
Product Development
Commercialization
Investors
